Anneka was told she had kidney failure in her 30s. The cause? Undetected high blood pressure. As cases skyrocket, she now reveals the signs that were missed - and the simple test everyone should take
Although she wasn't overly concerned about the risk of infection, she visited her GP for precautionary blood tests.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
12 minutes ago
- The Independent
Tool could help improve your fitness in just 30 minutes
An early trial suggests a small device that stimulates a major nerve connecting the heart and brain could help improve fitness. The device, clipped to the outer ear, sends gentle electrical pulses to increase the activity of the vagus nerve, which regulates heart function. Wearing the stimulator for just 30 minutes a day for a week increased oxygen intake during exercise by 4 per cent in healthy volunteers. The study, led by researchers at University College London and Queen Mary University of London, involved 28 healthy volunteers and was published in the European Heart Journal. While larger trials are needed, researchers hope the device could one day be used to improve fitness, reduce inflammation, and potentially aid people with heart conditions.
The Independent
12 minutes ago
- The Independent
Cancer drug demand drives higher sales for AstraZeneca
AstraZeneca has announced a jump in sales in recent months after a surge in demand for cancer drugs, as the pharmaceutical giant prepares to plug 50 billion dollars (£37 billion) into its US expansion. The drug-maker reported total revenues of 28 billion US dollars (£21 billion) for the first half of 2025. This is 11% higher, at constant exchange rates, than the same period a year ago. AstraZeneca said the uplift was largely driven by its oncology medicines, with product sales surging by 16% year on year, thanks to growth in demand for drugs including Tagrisso and Imfinzi. Revenues from oncology products, which refer to the diagnosis and treatment of cancer, made up 43% of the company's total sales. The group's pre-tax profit soared by 27% to 6.5 billion US dollars (£4.9 billion) for the first half, compared with last year. AstraZeneca, which is based in the UK, last week pledged a mammoth investment into the US over the next five years, where it generates the highest proportion of sales. The money will fund a new multibillion dollar manufacturing facility in Virginia, to be the firm's largest single manufacturing investment in the world. The new factory will produce drug substances for its growing weight management and metabolic portfolio, including oral GLP-1 products. GLP-1 is the scientific term for weight-loss medication, which works by reducing food cravings. Oral medicines can be taken in tablet form, while other drugs are taken as injections. 'Our strong momentum in revenue growth continued through the first half of the year and the delivery from our broad and diverse pipeline has been excellent,' Pascal Soriot, AstraZeneca's chief executive, said. 'This landmark investment reflects not only America's importance but also our confidence in our innovative medicines to transform global health and power AstraZeneca's ambition to deliver 80 billion dollars revenue by 2030.'
BBC News
13 minutes ago
- BBC News
Council warns planned care home too close to A47 in Norfolk
Plans for a care home could "end in tragedy" because dementia patients could "wander off", a council has Parish Council in Norfolk said it opposed the 60-bed home on the outskirts of Dereham as it was near "a treacherous junction" with the developers behind the proposal said there was lack of modern facilities in the area – and that residents would be monitored at all times.A report for Breckland Councillors advises them to give outline planning permission, on the basis that more care places are "much needed" in the area. Tilco – the firm behind the plan – wants to build the home next to Draytonhall Lane, on the south-western side of Dereham and near the land is within Scarning, where the parish council said the close proximity to a busy road was potentially dangerous. "It is not unheard of for dementia patients to wander off, and due to the location, it is thought this could end in tragedy," its objection also said it felt that a 25 space car park was too small for a location that would mainly be accessed by a report prepared for Tilco said "the safety of vulnerable residents and their possessions is a fundamental priority in the design" – with CCTV covering the building and the home's garden secured by hedges and also said the home would be "designed above current Care Quality Commission standards" and would employ between 50 and 60 full-time staff. The company's plans were rejected by councillors in 2023, on the basis that the site was too far from amenities in Dereham and too close to the decision went against the recommendation of council officers who are – as they did two years ago – advising that the plan should be given the their report, the officers advise that safety upgrades - including road markings and signage – had "been successful in reducing incidents" at the junction with the also state that Breckland is expected to require another 900 care beds by 2036, and those provided by another home are "much needed".They recommend that councillors give outline planning permission for the site – with fuller plans to be agreed at a later proposals will be discussed at a meeting of Breckland's planning committee next Tuesday. Follow Norfolk news on BBC Sounds, Facebook, Instagram and X.
